[go: up one dir, main page]

GT201300148A - COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR - Google Patents

COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR

Info

Publication number
GT201300148A
GT201300148A GT201300148A GT201300148A GT201300148A GT 201300148 A GT201300148 A GT 201300148A GT 201300148 A GT201300148 A GT 201300148A GT 201300148 A GT201300148 A GT 201300148A GT 201300148 A GT201300148 A GT 201300148A
Authority
GT
Guatemala
Prior art keywords
inhibitor
compositions
methods
mek
treat cancer
Prior art date
Application number
GT201300148A
Other languages
Spanish (es)
Inventor
Laurent Debussche
Carlos García-Echeverria
Jianguo Ma
Stuart Mcmillan
Janet Anne Meurer Ogden
Loic Vincent
Original Assignee
Sanofi Sa
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Merck Patent Gmbh filed Critical Sanofi Sa
Publication of GT201300148A publication Critical patent/GT201300148A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EN LA PRESENTE INVENCIÓN SE PROPORCIONAN PROCEDIMIENTOS PARA TRATAR PACIENTES CON CÁNCER, EN DONDE LOS PROCEDIMIENTOS COMPRENDEN ADMINISTRAR AL PACIENTE UNA CANTIDAD EFICAZ DE UN INHIBIDOR DE MEK Y UNA CANTIDAD EFICAZ DE UN INHIBIDOR DE PI3K. TAMBIÉN SE DESCRIBEN COMPOSICIONES EN LAS QUE LOS INHIBIDORES DE MEK Y DE PI3K ESTÁN EN COMBINACIÓNIN THE PRESENT INVENTION PROCEDURES ARE PROVIDED TO TREAT PATIENTS WITH CANCER, WHERE THE PROCEDURES INCLUDE TO ADMINISTER THE PATIENT AN EFFECTIVE AMOUNT OF A MEK INHIBITOR AND AN EFFICIENT AMOUNT OF A PI3K INHIBITOR. COMPOSITIONS ARE ALSO DESCRIBED IN WHICH THE MEK AND PI3K INHIBITORS ARE IN COMBINATION

GT201300148A 2010-12-09 2013-06-07 COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR GT201300148A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42146510P 2010-12-09 2010-12-09
US201161436258P 2011-01-26 2011-01-26

Publications (1)

Publication Number Publication Date
GT201300148A true GT201300148A (en) 2014-08-05

Family

ID=51540847

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201300148A GT201300148A (en) 2010-12-09 2013-06-07 COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR

Country Status (1)

Country Link
GT (1) GT201300148A (en)

Similar Documents

Publication Publication Date Title
ZA202208792B (en) Methods of treating and preventing graft versus host disease
MX2016004580A (en) USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA.
GT201300320A (en) COMBINATION THERAPY INCLUDING A CDK4 / 6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN CANCER TREATMENT.
DOP2013000131A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
MX2015011753A (en) Methods of treating bladder cancer.
MX373925B (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS.
DOP2015000098A (en) ADJUTIVE THERAPY WITH QUINASA INHIBITORS OF THE TEC FAMILY
CR20150571A (en) THERAPEUTIC COMPOUNDS AND COMPOSITIONS
CO6630162A2 (en) 1-amino -2-cyclopropylethylboronic acid derivatives
MX2015014596A (en) Combination therapy comprising a tor kinase inhibitor and an imid compound for treating cancer.
NI201200030A (en) ANTI-CANCER TREATMENT WITH A COMBINATION OF TAXANS AND 13-DEXOSYANTRACICLINES.
CO6531463A2 (en) COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR
MX2013003076A (en) Breast cancer therapeutics.
NI201400109A (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
NI201400110A (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
MX374749B (en) COMBINATION THERAPY INCLUDING A TOR KINASE INHIBITOR AND A CYTIDINE ANALOGUE TO TREAT CANCER.
NI201500055A (en) TREATMENT OF PROSTATE CANCER WITH TOR KINASE INHIBITORS
ECSP14013244A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING THE PI3Kbeta INHIBITOR AND THE MAPK ROUTE INHIBITOR, INCLUDING MEK AND RAF INHIBITORS
DOP2014000221A (en) METHODS TO TREAT CANCER USING PI3K INHIBITOR AND MEK INHIBITOR
UY35033A (en) FORMULATION IN TABLETS OF A 3-CINASA PHOSPHYTIDYLINOSITOL INHIBITOR
UA111714C2 (en) SYNERGIC FUNGICID COMBINATION
GT201300148A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR
NI201300052A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
CO6721062A2 (en) Cmpositions and methods to treat cancer using a pi3k inhibitor and a mek inhibitor
ECSP13012736A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR